Register for the Webinar

Improving Cancer Care and Drug Development with Methylation Data

Register here

"*" indicates required fields

Area of Interest
This field is for validation purposes and should be left unchanged.

GH Webinar
Sponsored by Guardant Health


In this webinar, Evi Lianidou, professor of clinical chemistry at the University of Athens, and Jacob Berchuck, medical oncologist at Dana-Farber Cancer Institute, will discuss how integrating methylation data in liquid biopsy applications can accelerate novel oncology therapeutics development.

Duration: 62 minutes

They will discuss applications including:

  • Methylation based gene silencing in breast, prostate, and lung cancer.
  • Detecting cell-free DNA based methylation signal for low shedding tumors.
  • Identifying novel predictive or prognostic markers to differentiate responders and non-responders.
  • Accelerating novel oncology drug development.


Evi Lianidou, PhD
Professor of Analytical Chemistry and Clinical Chemistry National and Kapodistrian University of Athens

Evi Lianidou is a professor of analytical chemistry and clinical chemistry in the department of chemistry at the University of Athens.

Jacob Berchuck, MD
Medical Oncologist Dana-Farber Cancer Institute

Jacob Berchuck is a medical oncologist in the Lank Center for Genitourinary Oncology at Dana-Farber Brigham Cancer Center.

Han-Yu Chuang, PhD
Vice President of Technology Guardant Health

Han-Yu Chuang is the vice president of technology at Guardant Health.